A dose of 1 mg to 100 mg of selective progesterone receptor modulator (sprm) for the treatment of endometriosis or uterine fibroids

摘要

The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods for treating endometriosis, dysmenorrhea, breast cancer, uterine fibroids and endometrial hyperproliferation.